Search Results
Page:12
Biosimilars & Biologics
Implementation and Monitoring in a Healthcare Setting
Edited by Steven Lucio
Chapter 1: A New Type of Blockbuster: The Growth of Biologics
Edited by Steven Lucio
Chapter 2: Déjà Vu or Something New?–Comparing the Generic and Biosimilar Experiences
Edited by Steven Lucio
Chapter 3: Bugs and Drugs, and Yeast and Mice, and Chinese Hamsters
Edited by Steven Lucio
Chapter 4: The $250 Billion Pyramid: Analytics in Biosimilarity Determination
Edited by Steven Lucio
Chapter 5: The Global Biosimilars Experience
Edited by Steven Lucio
Chapter 6: The American Biosimilar Experience: Red, White, and Possibly Interchangeable
Edited by Steven Lucio
Chapter 7: Biosimilar Clinical Trial Requirements
Edited by Steven Lucio
Chapter 8: Immunogenicity and Pharmacovigilance in the Biosimilar Era
Edited by Steven Lucio
Chapter 9: The Patent Dance and the Exclusivity Shuffle
Edited by Steven Lucio
Page:12